nicardipine has been researched along with ahc 52 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, Y; Watanabe, N; Yamashiro, T | 1 |
| Kobayashi, Y; Koga, C; Tsuruo, T; Watanabe, N; Yamashiro, T; Yokoyama, KK | 1 |
2 other study(ies) available for nicardipine and ahc 52
| Article | Year |
|---|---|
Reduction of intracellular pH by inhibitors of natural killer cell activity, nicardipine, methyl 2-(N-benzyl-N-methylamino)ethyl-2,6-dimethyl-4-(2-isopropyl-pyrazolo[1, 5-a]pyridine-3-yl)-1,4-dihydro-pyridine-3,5-dicarboxylate (AHC-52), and 4,4'-diisothio
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytotoxicity, Immunologic; Dihydropyridines; Flow Cytometry; Humans; Hydrogen-Ion Concentration; Killer Cells, Natural; Nicardipine; Pyrazoles; Tumor Cells, Cultured | 1997 |
Requirement of expression of P-glycoprotein on human natural killer leukemia cells for cell-mediated cytotoxicity.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Cell Survival; Cytotoxicity, Immunologic; Dihydropyridines; Drug Resistance, Multiple; Humans; Killer Cells, Natural; Nicardipine; Oligonucleotides, Antisense; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; RNA, Messenger; Thymoma; Thymus Neoplasms; Transcription, Genetic; Tumor Cells, Cultured | 1998 |